Non-muscle Invasive Bladder Cancer Market
Non-Muscle Invasive Bladder Cancer (NMIBC) is a common, heterogeneous disease confined to the bladder’s inner lining, sparing the muscle layer. It **** for 70–80% of newly diagnosed bladder cancers, including non-invasive papillary tumors (pTa), carcinoma in situ (CIS; pTis), and early invasive tumors (pT1). NMIBC has high recurrence rates of 50–70%, though only 10–20% progress to muscle-invasive bladder cancer (MIBC), necessitating ongoing, long-term surveillance.
Download the full infographic to uncover detailed insights: https://www.delveinsight.com/i....nfographics/non-musc
Comment
Share
